Cornerstone Wealth Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Cornerstone Wealth Management, LLC

  • $1.44 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$17.91 - $52.25 $118,331 - $345,215
-6,607 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$66.92 - $84.79 $133,840 - $169,580
-2,000 Reduced 23.24%
6,607 $555,000
Q3 2021

Nov 12, 2021
SELL
$46.83 - $73.5 $327,810 - $514,500
-7,000 Reduced 44.85%
8,607 $574,000
Q4 2020

Jan 29, 2021
BUY
$31.71 - $57.97 $494,897 - $904,737
15,607 New
15,607 $811,000

Others Institutions Holding ZNTL

# of Institutions
142
Shares Held
68M
Call Options Held
48.5K
Put Options Held
89.6K
View Full List

About Zentalis Pharmaceuticals, Inc.

ZNTL Quotes by TradingView
  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $127M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Cornerstone Wealth Management, LLC Portfolio

Follow Cornerstone Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email